BUR Burford Capital | $3.59 +3.6% | 11/12/2026 | | Set Price Target | $3.25 | Neutral | 00.00% | View details for Wedbush rating of Burford Capital (NYSE:BUR) on 11/12/2026 |
NVDA NVIDIA | $160.55 -3.4% | 11/12/2026 | | Set Price Target | $345.00 | Outperform | 00.00% | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 11/12/2026 |
CINT CI&T | $3.12 +1.0% | 11/12/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Wedbush rating of CI&T (NYSE:CINT) on 11/12/2026 |
MLTX MoonLake Immunotherapeutics | $12.69 -1.4% | 11/12/2026 | | Set Price Target | $34.00 | Outperform | 00.00% | View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 11/12/2026 |
DDI DoubleDown Interactive | $15.69 -0.1% | 11/12/2026 | | Set Price Target | $16.25 | Outperform | 00.00% | View details for Wedbush rating of DoubleDown Interactive (NASDAQ:DDI) on 11/12/2026 |
IMSR Terrestrial Energy | $2.57 +2.6% | 11/12/2026 | | Set Price Target | $4.00 | Neutral | 00.00% | View details for Wedbush rating of Terrestrial Energy (NASDAQ:IMSR) on 11/12/2026 |
BBOT BridgeBio Oncology Therapeutics | $2.18 -7.4% | 11/11/2026 | | Lower Price Target | $9.00 | Outperform | 00.00% | View details for Wedbush rating of BridgeBio Oncology Therapeutics (NASDAQ:BBOT) on 11/11/2026 |
BEAM Beam Therapeutics | $23.42 -2.6% | 11/11/2026 | | Boost Price Target | $30.00 ➝ $33.00 | Outperform | 00.00% | View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 11/11/2026 |
CGEM Cullinan Therapeutics | $10.12 -0.7% | 11/11/2026 | | Boost Price Target | $42.00 ➝ $44.00 | Outperform | 00.00% | View details for Wedbush rating of Cullinan Therapeutics (NASDAQ:CGEM) on 11/11/2026 |
GOSS Gossamer Bio | $10.83 -3.6% | 11/11/2026 | | Lower Price Target | $32.00 | Neutral | 00.00% | View details for Wedbush rating of Gossamer Bio (NASDAQ:GOSS) on 11/11/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
PEPG PepGen | $4.52 -10.4% | 11/11/2026 | | Boost Price Target | $4.00 ➝ $10.00 | Outperform | 00.00% | View details for Wedbush rating of PepGen (NASDAQ:PEPG) on 11/11/2026 |
TYRA Tyra Biosciences | $19.61 -0.8% | 11/11/2026 | | Boost Price Target | $53.00 ➝ $57.00 | Outperform | 00.00% | View details for Wedbush rating of Tyra Biosciences (NASDAQ:TYRA) on 11/11/2026 |
QUBT Quantum Computing | $5.50 -5.6% | 11/10/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Wedbush rating of Quantum Computing (NASDAQ:QUBT) on 11/10/2026 |
WIX Wix.com | $66.63 +1.1% | 11/10/2026 | | Lower Price Target | $80.00 ➝ $75.00 | Neutral | 00.00% | View details for Wedbush rating of Wix.com (NASDAQ:WIX) on 11/10/2026 |
CATX Perspective Therapeutics | $0.95 +13.2% | 11/10/2026 | | Reiterated Rating | $9.00 ➝ $7.00 | Outperform | 00.00% | View details for Wedbush rating of Perspective Therapeutics (NYSEAMERICAN:CATX) on 11/10/2026 |
LRMR Larimar Therapeutics | $2.96 +9.6% | 11/10/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Wedbush rating of Larimar Therapeutics (NASDAQ:LRMR) on 11/10/2026 |
CMPX Compass Therapeutics | $0.76 -7.1% | 11/10/2026 | | Lower Price Target | $1.00 ➝ $0.90 | Neutral | 00.00% | View details for Wedbush rating of Compass Therapeutics (NASDAQ:CMPX) on 11/10/2026 |
MAZE Maze Therapeutics | $34.40 -4.7% | 11/10/2026 | | Boost Price Target | $48.00 ➝ $49.00 | Outperform | 00.00% | View details for Wedbush rating of Maze Therapeutics (NASDAQ:MAZE) on 11/10/2026 |
NVCR NovoCure | $11.46 -2.3% | 11/10/2026 | | Lower Price Target | $20.00 ➝ $19.00 | Neutral | 00.00% | View details for Wedbush rating of NovoCure (NASDAQ:NVCR) on 11/10/2026 |
PRAX Praxis Precision Medicines | $319.06 -1.8% | 11/10/2026 | | Boost Price Target | $188.00 ➝ $189.00 | Underperform | 00.00% | View details for Wedbush rating of Praxis Precision Medicines (NASDAQ:PRAX) on 11/10/2026 |
QLYS Qualys | $169.95 -1.8% | 11/10/2026 | | Boost Price Target | $175.00 ➝ $185.00 | Neutral | 00.00% | View details for Wedbush rating of Qualys (NASDAQ:QLYS) on 11/10/2026 |
ROKU Roku | $159.65 -0.5% | 11/10/2026 | | Dropped Coverage | | Neutral | 00.00% | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 11/10/2026 |
TLS Telos | $7.46 -3.3% | 11/10/2026 | | Boost Price Target | $5.00 ➝ $7.00 | Neutral | 00.00% | View details for Wedbush rating of Telos (NASDAQ:TLS) on 11/10/2026 |
TNGX Tango Therapeutics | $24.65 -0.8% | 11/10/2026 | | Lower Price Target | $45.00 ➝ $40.00 | Outperform | 00.00% | View details for Wedbush rating of Tango Therapeutics (NASDAQ:TNGX) on 11/10/2026 |
TTD Trade Desk | $15.81 +2.2% | 11/10/2026 | | Reiterated Rating | $15.00 | Neutral | 00.00% | View details for Wedbush rating of Trade Desk (NASDAQ:TTD) on 11/10/2026 |
ZNTL Zentalis Pharmaceuticals | $1.70 +0.9% | 11/10/2026 | | Upgrade | $5.00 ➝ $6.00 | Neutral ➝ Outperform | 00.00% | View details for Wedbush rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 11/10/2026 |
PTGX Protagonist Therapeutics | $132.65 -1.3% | 11/9/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Wedbush rating of Protagonist Therapeutics (NASDAQ:PTGX) on 11/9/2026 |
CBRS Cerebras Systems | $105.06 +7.5% | 11/9/2026 | | Lower Price Target | $290.00 ➝ $190.00 | Outperform | 00.00% | View details for Wedbush rating of Cerebras Systems (NASDAQ:CBRS) on 11/9/2026 |
OKLO Oklo | $23.28 -4.8% | 11/9/2026 | | Reiterated Rating | $36.00 | Outperform | 00.00% | View details for Wedbush rating of Oklo (NYSE:OKLO) on 11/9/2026 |
IMAX IMAX | $47.86 -0.1% | 11/6/2026 | | Boost Price Target | $60.00 ➝ $62.00 | Outperform | 00.00% | View details for Wedbush rating of IMAX (NYSE:IMAX) on 11/6/2026 |
PLTK Playtika | $2.48 -0.6% | 11/6/2026 | | Lower Price Target | $4.00 ➝ $3.00 | Neutral | 00.00% | View details for Wedbush rating of Playtika (NASDAQ:PLTK) on 11/6/2026 |
U Unity Software | $50.83 +1.3% | 11/6/2026 | | Boost Price Target | $55.00 ➝ $63.00 | Outperform | 00.00% | View details for Wedbush rating of Unity Software (NYSE:U) on 11/6/2026 |
VERA Vera Therapeutics | $28.22 -2.8% | 11/6/2026 | | Lower Price Target | $34.00 ➝ $29.00 | Neutral | 00.00% | View details for Wedbush rating of Vera Therapeutics (NASDAQ:VERA) on 11/6/2026 |
ABNB Airbnb | $185.38 +2.3% | 11/6/2026 | | Boost Price Target | $200.00 ➝ $237.00 | Outperform | 00.00% | View details for Wedbush rating of Airbnb (NASDAQ:ABNB) on 11/6/2026 |
AVTX Avalo Therapeutics | $7.84 +1.8% | 11/6/2026 | | Lower Price Target | $22.00 ➝ $20.00 | Outperform | 00.00% | View details for Wedbush rating of Avalo Therapeutics (NASDAQ:AVTX) on 11/6/2026 |
CGON CG Oncology | $72.48 +3.3% | 11/6/2026 | | Boost Price Target | $80.00 ➝ $84.00 | Outperform | 00.00% | View details for Wedbush rating of CG Oncology (NASDAQ:CGON) on 11/6/2026 |
CTMX CytomX Therapeutics | $2.00 -2.2% | 11/6/2026 | | Boost Price Target | $11.00 ➝ $12.00 | Outperform | 00.00% | View details for Wedbush rating of CytomX Therapeutics (NASDAQ:CTMX) on 11/6/2026 |
EPAM EPAM Systems | $167.55 +2.3% | 11/6/2026 | | Boost Price Target | $99.00 ➝ $160.00 | Neutral | 00.00% | View details for Wedbush rating of EPAM Systems (NYSE:EPAM) on 11/6/2026 |
JANX Janux Therapeutics | $11.24 -2.2% | 11/6/2026 | | Boost Price Target | $36.00 ➝ $40.00 | Outperform | 00.00% | View details for Wedbush rating of Janux Therapeutics (NASDAQ:JANX) on 11/6/2026 |
PYXS Pyxis Oncology | $1.54 -2.8% | 11/6/2026 | | Lower Price Target | $8.00 ➝ $7.00 | Outperform | 00.00% | View details for Wedbush rating of Pyxis Oncology (NASDAQ:PYXS) on 11/6/2026 |
URGENT: If you own a home, please review the map below. (Ad) More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards urges homeowners to check the map and see whether one is near them.
Families in Georgia have been forced to sell, entire Ohio neighborhoods are being torn down, and nearly 50,000 Lake Tahoe residents face losing power.
Rickards advised the Pentagon and the U.S. intelligence community for decades. He says one man outside Washington can stop it. See the map and get the full details on what this means for you |
CLYM Climb Bio | $10.45 -3.9% | 11/5/2026 | | Boost Price Target | $25.00 ➝ $27.00 | Outperform | 00.00% | View details for Wedbush rating of Climb Bio (NASDAQ:CLYM) on 11/5/2026 |
CHH Choice Hotels International | $119.09 +0.7% | 11/5/2026 | | Set Price Target | $130.00 | | 00.00% | View details for Wedbush rating of Choice Hotels International (NYSE:CHH) on 11/5/2026 |
EXPE Expedia Group | $263.72 +1.0% | 11/5/2026 | | Lower Price Target | $417.00 ➝ $384.00 | Outperform | 00.00% | View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 11/5/2026 |
W Wayfair | $111.25 -0.2% | 11/5/2026 | | Boost Price Target | $125.00 ➝ $138.00 | Neutral | 00.00% | View details for Wedbush rating of Wayfair (NYSE:W) on 11/5/2026 |
APP AppLovin | $409.62 +4.0% | 11/5/2026 | | Boost Price Target | $560.00 ➝ $600.00 | Outperform | 00.00% | View details for Wedbush rating of AppLovin (NASDAQ:APP) on 11/5/2026 |
BCRX BioCryst Pharmaceuticals | $7.54 -1.9% | 11/5/2026 | | Lower Price Target | $18.00 ➝ $17.00 | Outperform | 00.00% | View details for Wedbush rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 11/5/2026 |
CRTO Criteo | $17.67 +1.4% | 11/5/2026 | | Lower Price Target | $25.00 ➝ $21.00 | Outperform | 00.00% | View details for Wedbush rating of Criteo (NASDAQ:CRTO) on 11/5/2026 |
DDOG Datadog | $180.25 -2.3% | 11/5/2026 | | Lower Price Target | $275.00 ➝ $240.00 | Outperform | 00.00% | View details for Wedbush rating of Datadog (NASDAQ:DDOG) on 11/5/2026 |
EWTX Edgewise Therapeutics | $44.41 -3.1% | 11/5/2026 | | Lower Price Target | $53.00 ➝ $51.00 | Outperform | 00.00% | View details for Wedbush rating of Edgewise Therapeutics (NASDAQ:EWTX) on 11/5/2026 |
GFS GlobalFoundries | $40.91 -4.0% | 11/5/2026 | | Lower Price Target | $72.00 ➝ $45.00 | Neutral | 00.00% | View details for Wedbush rating of GlobalFoundries (NASDAQ:GFS) on 11/5/2026 |
RCUS Arcus Biosciences | $17.19 -3.3% | 11/5/2026 | | Lower Price Target | $49.00 ➝ $45.00 | Outperform | 00.00% | View details for Wedbush rating of Arcus Biosciences (NYSE:RCUS) on 11/5/2026 |
UBER Uber Technologies | $69.52 +0.6% | 11/5/2026 | | Reiterated Rating | $91.00 | Outperform | 00.00% | View details for Wedbush rating of Uber Technologies (NYSE:UBER) on 11/5/2026 |
VRDN Viridian Therapeutics | $30.35 -0.4% | 11/5/2026 | | Boost Price Target | $41.00 ➝ $42.00 | Outperform | 00.00% | View details for Wedbush rating of Viridian Therapeutics (NASDAQ:VRDN) on 11/5/2026 |
XMTR Xometry | $119.83 -0.8% | 11/4/2026 | | Boost Price Target | $126.00 ➝ $140.00 | Outperform | 00.00% | View details for Wedbush rating of Xometry (NASDAQ:XMTR) on 11/4/2026 |
DUOL Duolingo | $162.19 +3.0% | 11/4/2026 | | Boost Price Target | $150.00 ➝ $155.00 | Neutral | 00.00% | View details for Wedbush rating of Duolingo (NASDAQ:DUOL) on 11/4/2026 |
AMD Advanced Micro Devices | $527.07 -9.9% | 11/4/2026 | | Reiterated Rating | $600.00 | Outperform | 00.00% | View details for Wedbush rating of Advanced Micro Devices (NASDAQ:AMD) on 11/4/2026 |
BEAM Beam Therapeutics | $23.42 -2.6% | 11/4/2026 | | Boost Price Target | $28.00 ➝ $30.00 | Outperform | 00.00% | View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 11/4/2026 |
BKNG Booking | $161.23 +0.0% | 11/4/2026 | | Lower Price Target | $247.00 ➝ $210.00 | Outperform | 00.00% | View details for Wedbush rating of Booking (NASDAQ:BKNG) on 11/4/2026 |
CNK Cinemark | $40.96 -1.2% | 11/4/2026 | | Boost Price Target | $45.00 ➝ $46.00 | Outperform | 00.00% | View details for Wedbush rating of Cinemark (NYSE:CNK) on 11/4/2026 |
DNLI Denali Therapeutics | $18.70 -1.0% | 11/4/2026 | | Boost Price Target | $23.00 ➝ $24.00 | Outperform | 00.00% | View details for Wedbush rating of Denali Therapeutics (NASDAQ:DNLI) on 11/4/2026 |
DT Dynatrace | $44.31 -1.3% | 11/4/2026 | | Lower Price Target | $54.00 ➝ $50.00 | Neutral | 00.00% | View details for Wedbush rating of Dynatrace (NYSE:DT) on 11/4/2026 |
HURN Huron Consulting Group | $170.35 +1.9% | 11/4/2026 | | Boost Price Target | $160.00 ➝ $220.00 | Outperform | 00.00% | View details for Wedbush rating of Huron Consulting Group (NASDAQ:HURN) on 11/4/2026 |
IDYA IDEAYA Biosciences | $31.14 -1.1% | 11/4/2026 | | Boost Price Target | $60.00 ➝ $63.00 | Outperform | 00.00% | View details for Wedbush rating of IDEAYA Biosciences (NASDAQ:IDYA) on 11/4/2026 |
RARE Ultragenyx Pharmaceutical | $16.09 -1.1% | 11/4/2026 | | Lower Price Target | $25.00 ➝ $22.00 | Neutral | 00.00% | View details for Wedbush rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 11/4/2026 |
SHOP Shopify | $146.30 -0.3% | 11/4/2026 | | Reiterated Rating | $176.00 | Outperform | 00.00% | View details for Wedbush rating of Shopify (NASDAQ:SHOP) on 11/4/2026 |
SYRE Spyre Therapeutics | $102.75 -0.2% | 11/4/2026 | | Lower Price Target | $123.00 ➝ $120.00 | Outperform | 00.00% | View details for Wedbush rating of Spyre Therapeutics (NASDAQ:SYRE) on 11/4/2026 |
NET Cloudflare | $304.93 -4.3% | 11/3/2026 | | Initiated Coverage | | Outperform | 00.00% | View details for Wedbush rating of Cloudflare (NYSE:NET) on 11/3/2026 |
TSEM Tower Semiconductor | $144.15 -8.7% | 11/3/2026 | | Lower Price Target | $300.00 ➝ $190.00 | Neutral | 00.00% | View details for Wedbush rating of Tower Semiconductor (NASDAQ:TSEM) on 11/3/2026 |
STRT Strattec Security | $62.48 +0.2% | 11/3/2026 | | Set Price Target | $79.00 | | 00.00% | View details for Wedbush rating of Strattec Security (NASDAQ:STRT) on 11/3/2026 |
GFUZ General Fusion Group | $5.23 -4.0% | 11/3/2026 | | Initiated Coverage | $7.00 | Neutral | 00.00% | View details for Wedbush rating of General Fusion Group (NASDAQ:GFUZ) on 11/3/2026 |
IMSR Terrestrial Energy | $2.57 +2.6% | 11/3/2026 | | Initiated Coverage | $4.00 | Neutral | 00.00% | View details for Wedbush rating of Terrestrial Energy (NASDAQ:IMSR) on 11/3/2026 |
OKLO Oklo | $23.28 -4.8% | 11/3/2026 | | Initiated Coverage | $36.00 | Outperform | 00.00% | View details for Wedbush rating of Oklo (NYSE:OKLO) on 11/3/2026 |
SMR NuScale Power | $4.61 -4.5% | 11/3/2026 | | Initiated Coverage | $5.00 | Underperform | 00.00% | View details for Wedbush rating of NuScale Power (NYSE:SMR) on 11/3/2026 |
XE X-Energy | $10.60 -5.9% | 11/3/2026 | | Initiated Coverage | $17.00 | Outperform | 00.00% | View details for Wedbush rating of X-Energy (NASDAQ:XE) on 11/3/2026 |
NNE Nano Nuclear Energy | $11.03 -0.6% | 11/2/2026 | | Initiated Coverage | $18.00 | Outperform | 00.00% | View details for Wedbush rating of Nano Nuclear Energy (NASDAQ:NNE) on 11/2/2026 |
NUE Nucor | $254.79 -2.3% | 11/2/2026 | | Set Price Target | $304.00 | | 00.00% | View details for Wedbush rating of Nucor (NYSE:NUE) on 11/2/2026 |
TTWO Take-Two Interactive Software | $228.78 +0.8% | 11/2/2026 | | Reiterated Rating | $280.00 | Outperform | 00.00% | View details for Wedbush rating of Take-Two Interactive Software (NASDAQ:TTWO) on 11/2/2026 |
AMZN Amazon.com | $264.51 -1.1% | 10/30/2026 | | Lower Price Target | $310.00 ➝ $298.00 | Outperform | 00.00% | View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 10/30/2026 |
CART Maplebear | $58.75 +0.5% | 10/30/2026 | | Downgrade | $63.00 ➝ $65.00 | Outperform ➝ Hold | 00.00% | View details for Wedbush rating of Maplebear (NASDAQ:CART) on 10/30/2026 |
DASH DoorDash | $172.48 -0.1% | 10/30/2026 | | Upgrade | $220.00 ➝ $230.00 | Neutral ➝ Outperform | 00.00% | View details for Wedbush rating of DoorDash (NASDAQ:DASH) on 10/30/2026 |
PINS Pinterest | $18.95 -0.9% | 10/30/2026 | | Lower Price Target | $24.00 ➝ $20.00 | Neutral | 00.00% | View details for Wedbush rating of Pinterest (NYSE:PINS) on 10/30/2026 |
RBLX Roblox | $50.72 -1.4% | 10/30/2026 | | Lower Price Target | $55.00 ➝ $52.00 | Neutral | 00.00% | View details for Wedbush rating of Roblox (NYSE:RBLX) on 10/30/2026 |
RDDT Reddit | $99.88 +0.3% | 10/30/2026 | | Lower Price Target | $221.00 ➝ $150.00 | Outperform | 00.00% | View details for Wedbush rating of Reddit (NYSE:RDDT) on 10/30/2026 |
TENB Tenable | $39.97 -2.6% | 10/29/2026 | | Boost Price Target | $29.00 ➝ $35.00 | Underperform | 00.00% | View details for Wedbush rating of Tenable (NASDAQ:TENB) on 10/29/2026 |
FTNT Fortinet | $126.33 -2.5% | 10/29/2026 | | Reiterated Rating | $155.00 ➝ $140.00 | Neutral | 00.00% | View details for Wedbush rating of Fortinet (NASDAQ:FTNT) on 10/29/2026 |
ETSY Etsy | $89.33 +1.2% | 10/29/2026 | | Boost Price Target | $88.00 ➝ $99.00 | Neutral | 00.00% | View details for Wedbush rating of Etsy (NYSE:ETSY) on 10/29/2026 |
EBAY eBay | $121.33 +1.0% | 10/29/2026 | | Boost Price Target | $137.00 ➝ $153.00 | Outperform | 00.00% | View details for Wedbush rating of eBay (NASDAQ:EBAY) on 10/29/2026 |
BCAX Bicara Therapeutics | $9.85 -2.6% | 10/29/2026 | | Lower Price Target | $33.00 ➝ $24.00 | Outperform | 00.00% | View details for Wedbush rating of Bicara Therapeutics (NASDAQ:BCAX) on 10/29/2026 |
BIIB Biogen | $250.76 +0.1% | 10/29/2026 | | Boost Price Target | $212.00 ➝ $225.00 | Neutral | 00.00% | View details for Wedbush rating of Biogen (NASDAQ:BIIB) on 10/29/2026 |
DBD Diebold Nixdorf | $55.45 +1.3% | 10/29/2026 | | Lower Price Target | $100.00 ➝ $90.00 | Outperform | 00.00% | View details for Wedbush rating of Diebold Nixdorf (NYSE:DBD) on 10/29/2026 |
A little-known law has been quietly applied to your savings for years. (Ad) Fox News reported that under current law, legal title to most stocks and bonds sits with a central institution, Cede and Company, not the individual investor.
If a brokerage collapses and customer securities were pledged as collateral, secured creditors can legally come before account holders.
Physical gold held in a self-directed IRA is registered directly to you, with no clearinghouse or central institution holding its title. Request your free 2026 Gold Guide and learn your options today |
GOOGL Alphabet | $294.33 -1.5% | 10/29/2026 | | Lower Price Target | $445.00 ➝ $387.00 | Outperform | 00.00% | View details for Wedbush rating of Alphabet (NASDAQ:GOOGL) on 10/29/2026 |
GERN Geron | $0.96 -3.3% | 10/28/2026 | | Lower Price Target | $5.00 | Outperform | 00.00% | View details for Wedbush rating of Geron (NASDAQ:GERN) on 10/28/2026 |
ACRS Aclaris Therapeutics | $3.91 -2.4% | 10/28/2026 | | Lower Price Target | $10.00 ➝ $8.00 | Outperform | 00.00% | View details for Wedbush rating of Aclaris Therapeutics (NASDAQ:ACRS) on 10/28/2026 |
BEAM Beam Therapeutics | $23.42 -2.6% | 10/28/2026 | | Lower Price Target | $65.00 ➝ $28.00 | Outperform | 00.00% | View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 10/28/2026 |
KNSA Kiniksa Pharmaceuticals International | $95.47 -0.8% | 10/28/2026 | | Boost Price Target | $99.00 ➝ $102.00 | Outperform | 00.00% | View details for Wedbush rating of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) on 10/28/2026 |
STX Seagate Technology | $514.58 -5.6% | 10/28/2026 | | Reiterated Rating | $1,000.00 | Outperform | 00.00% | View details for Wedbush rating of Seagate Technology (NASDAQ:STX) on 10/28/2026 |
AVGO Broadcom | $342.25 -6.1% | 10/27/2026 | | Initiated Coverage | | Outperform | 00.00% | View details for Wedbush rating of Broadcom (NASDAQ:AVGO) on 10/27/2026 |
ARTV Artiva Biotherapeutics | $3.99 +0.6% | 10/27/2026 | | Downgrade | $4.00 | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Artiva Biotherapeutics (NASDAQ:ARTV) on 10/27/2026 |
FATE Fate Therapeutics | $1.25 -7.1% | 10/27/2026 | | Reiterated Rating | $7.00 | Outperform | 00.00% | View details for Wedbush rating of Fate Therapeutics (NASDAQ:FATE) on 10/27/2026 |
IMNM Immunome | $18.55 -0.8% | 10/27/2026 | | Reiterated Rating | $35.00 | Outperform | 00.00% | View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 10/27/2026 |